Brief: Burning Rock Biotech ADS Open At $22.80 In Debut On The Nasdaq Versus IPO Price Of $16.50 Per ADS
12/06/2020 16:36
June 12 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK BIOTECH ADS OPEN AT $22.80 IN DEBUT ON THE
NASDAQ
VERSUS IPO PRICE OF $16.50 PER ADS
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer